Kinnevik led a $51m Series B1 round in Enveda Biosciences.

Synopsis

Kinnevik, an investment company, led a $51m Series B1 round in Enveda Biosciences, a drug discovery and development company, with participation from Henry Kravis, FPV, True Ventures, and Wireframe.

Principals

target

Enveda Biosciences

bidder

Kinnevik

Show Details & Financials

Did you work on this deal?

Claim Deal

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Claim Deal

Market Context